期刊文献+

肌钙蛋白T和脑钠肽水平对非ST段抬高型心肌梗死诊断及预后的临床意义 被引量:9

Observation of cTnT and BNP level in the Diagnosis and Prognosis of NSTEMI
在线阅读 下载PDF
导出
摘要 目的探讨肌钙蛋白T和脑钠肽水平对非ST段抬高型心肌梗死早期诊断和预后的价值。方法以急性非ST段抬高型心肌梗死病人60例及体检健康者50例为研究对象,对血清肌钙蛋白T(cTnT)和脑钠肽(BNP)水平的变化作相关性比较分析。结果实验组血清cTnT和血清BNP水平明显高于正常对照组(P<0.01),同时实验组中BNP高峰持续时间明显长于cTnT(P<0.01),且BNP高峰持续时间长者发生心衰的危险性明显增高(P<0.01)。结论血清cTnT与BNP水平对于非ST段抬高型心肌梗死的早期诊断无明显差别,BNP在预后方面有明显的参考价值。 Objective To study the benefits about cTnT and BNP in early diagnosis and prognosis for non-ST elevated myocardiac infarction(NSTEMI).Methods To collect patients with acute NSTEMI and healthy volunteers as study objects,dynamically monitor serum cTnT and BNP and compare their relationship.Results The level of serum cTnT and BNP in study group was significantly higher than the control group(P0.01),and the peak of BNP lasted significantly longer than cTnT(P0.01),and there was significant relationship between high BNP and the incidence of heart failure(P0.01).Conclusions There are no differences between cTnT and BNP in early diagnosis about NSTEMI,but BNP is important to the prognosis of myocardial infarction.
出处 《中南医学科学杂志》 CAS 2012年第2期168-170,共3页 Medical Science Journal of Central South China
  • 相关文献

参考文献9

  • 1James SK,Lindahl B,Siegbahn A. N-terminal probrain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease:a Global Utilization of Strategies To Open occluded arteries (GUSTO)-Ⅳ substudy[J].Circulation,2003,(03):275-281.doi:10.1161/01.CIR.0000079170.10579.DC.
  • 2Wiezorek SJ,Wu AH,Christ ER. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure:a multi center evaluation[J].American Heart Journal,2002.834-839.
  • 3Weber M,Bazzino O,Navarro Estrada JL. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission[J].Journal of the American College of Cardiology,2008,(12):1188-1195.doi:10.1016/j.jacc.2007.11.054.
  • 4De Lemos JA,Morrow DA,Blazing MA. Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes:results from the A to Z trial[J].American Journal of Cardiology,2007,(27):2117-2124.
  • 5Morrow DA,de Lemos JA,Blazing MA. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease[J].Journal of the American Medical Association,2005,(22):2866-2871.doi:10.1001/jama.294.22.2866.
  • 6Palazzuoli A,Deckers J,Calabro A. Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function[J].American Journal of Cardiology,2006,(10):1322-1328.
  • 7Sinclair H,Paterson M,Walker S. Predicting outcome in patients with acute coronary syndrome:evaluation of B-type natriuretic peptide and the global registry of acute coronary events (GRACE) risk score[J].Scottish Medical Journal,2007,(03):8-13.doi:10.1258/rsmsmj.52.3.8.
  • 8de Lemos JA,Morrow DA,Bentley JH. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes[J].New England Journal of Medicine,2001,(14):1014-1021.
  • 9Palazzuoli A,Gennari L,Calabira P. Relation of plasma brain natriuretic peptide levels in non-ST-elevation coronary disease and preserved systolic function to number of narrowed coronary arteries[J].American Journal of Cardiology,2005,(12):1705-1710.doi:10.1016/j.amjcard.2005.07.094.

同被引文献103

引证文献9

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部